Abound Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
196
+6
| +3% | +$4.69K | 0.04% | 96 |
|
|
2025
Q1 | $157K | Buy |
190
+31
| +19% | +$25.7K | 0.05% | 83 |
|
|
2024
Q4 | $123K | Buy |
159
+2
| +1% | +$1.55K | 0.04% | 92 |
|
|
2024
Q3 | $139K | Buy |
157
+8
| +5% | +$7.11K | 0.05% | 81 |
|
|
2024
Q2 | $135K | Sell |
149
-23
| -13% | -$20.9K | 0.05% | 72 |
|
|
2024
Q1 | $134K | Buy |
172
+4
| +2% | +$3.12K | 0.05% | 73 |
|
|
2023
Q4 | $98K | Sell |
168
-3
| -2% | -$1.75K | 0.04% | 89 |
|
|
2023
Q3 | $91.9K | Sell |
171
-2
| -1% | -$1.08K | 0.04% | 81 |
|
|
2023
Q2 | $81.2K | Buy |
173
+38
| +28% | +$17.8K | 0.03% | 92 |
|
|
2023
Q1 | $46.4K | Sell |
135
-24
| -15% | -$8.25K | 0.02% | 129 |
|
|
2022
Q4 | $58.3K | Buy |
159
+37
| +30% | +$13.6K | 0.03% | 103 |
|
|
2022
Q3 | $39.5K | Buy |
+122
| New | +$39.5K | 0.02% | 131 |
|